Quick Answer
Regenerative Medical Technology Group Inc. reported Total Assets of $3.82 million for the year ending 2024.
- Regenerative Medical Technology Group Inc. showed an increase of +32.7% in Total Assets from 2023 to 2024.
- This data is from Regenerative Medical Technology Group Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2017 to 2024 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $4.2 thousand | Q2 2019: $43.5 thousand | Q3 2019: $3.2 thousand | Q1 2020: $14.1 thousand | Q2 2020: $64.2 thousand | Q3 2020: $236.9 thousand | Q1 2021: $964.7 thousand | Q2 2021: $10.92 million | Q3 2021: $17.07 million | Q1 2022: $8.96 million | Q2 2022: $8.37 million | Q3 2022: $8.23 million | Q1 2023: $8.07 million | Q2 2023: $7.54 million | Q3 2023: $3.31 million | Q1 2024: $3.08 million | Q2 2024: $3.05 million | Q3 2024: $3.23 million | Q4 2024: $3.82 million | Q1 2025: $3.98 million | Q2 2025: $4.49 million | Q3 2025: $4.52 million.
- Over the full 8 years of available data (2017 to 2024), Regenerative Medical Technology Group Inc.'s Total Assets has grown by 48,524.9%.
- Historical annual values: Fiscal year 2024: $3.82 million | Fiscal year 2023: $2.88 million | Fiscal year 2022: $8.08 million | Fiscal year 2021: $9.31 million | Fiscal year 2020: $219.7 thousand | Fiscal year 2019: $26.4 thousand | Fiscal year 2018: $34.6 thousand | Fiscal year 2017: $7.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: